SCHEMBL29993175

SCHEMBL29993175

CN(Cc1ccccc1)C(=O)C[Zn]

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.75
RAB9A P51151 3/20 0.75
KMT2A Q03164 3/20 0.68
CA12 O43570 2/20 0.63
CA9 Q16790 2/20 0.63
SMN1; SMN2 Q16637 2/20 0.62
ALDH1A1 P00352 1/20 0.58
POLB P06746 1/20 0.58
TSPO P30536 1/20 0.57
MEN1 O00255 1/20 0.56
MAPK1 P28482 1/20 0.55
HPGD P15428 2/20 0.54
RIPK1 Q13546 1/20 0.54
AOC3 Q16853 1/20 0.53
MGLL Q99685 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163935 0.84 NPC1 (0.75) NPC1RAB9AKMT2ACA12CA9
SCHEMBL1516137 0.84 NPC1 (0.75) NPC1RAB9AKMT2ACA12CA9
SCHEMBL544271 0.84 NPC1 (0.75) NPC1RAB9AKMT2ACA12CA9
SCHEMBL544272 0.84 NPC1 (0.75) NPC1RAB9AKMT2ACA12CA9
SCHEMBL180384 0.83 NPC1 (0.73) NPC1RAB9AKMT2ACA12CA9
SCHEMBL991685 0.82 RAB9A (0.72) NPC1RAB9AKMT2ACA12CA9
SCHEMBL3301637 0.82 NPC1 (0.72) NPC1RAB9AKMT2ACA12CA9
SCHEMBL6632648 0.82 AOC3 (0.73) NPC1RAB9AKMT2ACA12CA9
SCHEMBL11192974 0.82 NPC1 (0.85) NPC1RAB9AKMT2ACA12CA9
SCHEMBL4939224 0.82 RAB9A (0.72) NPC1RAB9AKMT2ACA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334285-A1 CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS Kare Chemical Technologies Inc. (CA) 2024-03-13 EP disclosed
WO-2022232931-A1 CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2022-11-10 WO disclosed